Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01756365Recruiting
Stem cell eye treatment from your own cornea cells
This trial tests an eye treatment made from your own cornea surface cells, grown in a lab and put back into the eye. It may help people with limbal stem cell deficiency by improving the health of the eye surface after a cell biopsy.
Toronto, OntarioAges 1 year+ - NCT04085406Recruiting
Deep brain stimulation for hard-to-treat low back pain
This trial studies deep brain stimulation (DBS) to reduce severe low back pain that hasn’t improved after many standard treatments and procedures. It may help people whose pain is long-lasting and not fixable with another surgery.
Los Angeles, CaliforniaAges 40–75 - NCT05890599Recruiting
Yoga or health education for ongoing fatigue after COVID
This trial studies whether a yoga program (compared with health education) can reduce persistent tiredness after COVID-19. It may help if your fatigue has lasted at least 12 weeks and you think it started with COVID.
StuttgartAges 18–65 - NCT06831942Recruiting
Suicide prevention counseling for adults 65 and older
This study tests a short counseling program for older adults (65+) who have recently attempted suicide or had serious suicidal thoughts. The program is designed to help reduce the risk of future suicide attempts. It is offered alongside your regular mental health care.
BoråsAges 65 years+ - NCT06829797RecruitingPhase 2
Iparomlimab and chemotherapy vs chemotherapy alone for stomach cancer
This trial tests whether adding an immunotherapy drug (Iparomlimab and Tuvonralimab, combined as QL1706) to standard chemotherapy before surgery works better than chemotherapy alone for people with locally advanced stomach or gastroesophageal junction cancer that can be surgically removed.
Jinan, ShandongAges 18–75 - NCT06833983RecruitingPhase 3
Study of GS1191-0445 injection for hemophilia A
This trial tests a new injection called GS1191-0445 for people with hemophilia A. It aims to see if it is safe and works well to prevent or treat bleeding episodes.
Hefei, AnhuiAges 18–65 - NCT06827990Recruiting
Stent graft for type A aortic dissection
This trial tests a stent graft device to repair a tear in the main artery from the heart (aorta). It is for people who have a high-risk condition called Type A aortic dissection and are not good candidates for open heart surgery.
Birmingham, AlabamaAges 18 years+ - NCT06829784RecruitingPhase 3
Study of TQC2731 for severe asthma
This trial tests an investigational drug called TQC2731 for people with severe asthma that is not well controlled despite high-dose inhaled steroids. The study aims to see if this treatment can reduce asthma attacks.
Bozhou, AnhuiAges 18–75 - NCT06826430RecruitingPhase 1
CAR-T cell therapy for severe lupus-related low platelets
This trial tests a new CAR-T cell treatment called Inaticabtagene Autoleucel for people with lupus that causes very low platelet counts (immune thrombocytopenia) that hasn't gotten better with standard treatments. The goal is to see if it can help raise platelet levels.
Beijing, Beijing MunicipalityAges 18–70 - NCT06828328RecruitingEarly Phase 1
Gene-edited TIL therapy for pancreatic cancer
This trial tests a new treatment called GC203 TIL, which uses your own immune cells (TILs) that have been gene-edited to fight pancreatic cancer. It is for people whose cancer has not responded to standard treatments and who are healthy enough to undergo this therapy.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06828939Recruiting
Balloon treatment for atrial fibrillation
This trial tests a new balloon device that uses gentle energy pulses to treat atrial fibrillation (AF), a type of irregular heartbeat. It may help people whose AF has not improved with medication.
Prague, Czech RepublicAges 18–75 - NCT06830889RecruitingPhase 3
BL-M07D1 vs T-DM1 for HER2-positive breast cancer after neoadjuvant therapy
This trial tests whether a new drug called BL-M07D1 works better than an existing drug, T-DM1, for people with HER2-positive breast cancer who still have cancer cells after initial treatment (neoadjuvant therapy). The goal is to prevent the cancer from coming back.
Nanjing, JiangsuAges 18–75 - NCT06830031RecruitingPhase 1
C402-CD19-CAR treatment for relapsed or refractory B-cell lymphoma
This trial tests a new CAR-T cell therapy called C402-CD19-CAR for people with certain types of B-cell lymphoma that have come back or not responded to previous treatments. The treatment uses your own immune cells to target and kill cancer cells that have a protein called CD19 on their surface.
TianjinAges 18–75 - NCT06831734Enrolling by invitation
Real-world safety study of Alhemo in hemophilia
This trial will track how well Alhemo works and how safe it is for people with hemophilia A or B in everyday use. If you are 12 or older and your doctor has already decided to start you on Alhemo, this study will collect information to help doctors better understand the medicine's real-world benefits and risks.
ChibaAges 12 years+ - NCT06830720Recruiting
Kisqali with hormone therapy for early-stage breast cancer
This study looks at how well Kisqali (ribociclib) combined with hormone therapy works after surgery for people with early-stage HR+ HER2- breast cancer that has a high chance of coming back. It aims to gather real-world data on different treatment options.
Wiener Neustadt, Lower AustriaAges 18–100 - NCT04873102RecruitingPhase 2
Danazol for low blood counts in some people with cirrhosis
This Phase 2 study tests danazol to improve low blood counts (low white blood cells and/or low platelets) in people with certain types of cirrhosis. It also looks at who may benefit, especially those with specific inherited blood-telomere changes.
Los Angeles, CaliforniaAges 18 years+ - NCT06831435Recruiting
Digital therapy for depression study
This study tests if a digital cognitive behavioral therapy program can help treat depression in real-world settings. It is designed for people aged 14 to 60 who have moderate to severe depression symptoms.
Beijing, Beijing MunicipalityAges 14–60 - NCT06833255Recruiting
Support Program for Black Women Breast Cancer Survivors
This program pairs Black women who have completed breast cancer treatment with support to help them transition into survivorship. It offers mentorship based on how recently you finished treatment, with priority for those who had limited support or who identify as African American.
Buffalo, New YorkAges 18 years+ - NCT06832605Recruiting
Mindfulness classes by video to prevent depression relapse
This trial tests an 8-week mindfulness-based cognitive therapy program delivered via video call to help people with a history of depression prevent future episodes. It may help you learn skills to manage low mood and reduce the chance of relapse.
Elche, AlicanteAges 18 years+ - NCT06832800RecruitingEarly Phase 1
Testing a new tool to manage jaundice in newborns
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
HangzhouAges 4 hours–4 weeks - NCT06833944Recruiting
High-intensity exercise for inherited high cholesterol
This trial tests whether a program of high-intensity interval training can help people with familial hypercholesterolemia (an inherited condition that causes very high cholesterol). It aims to see if exercise can improve cholesterol levels and heart health.
Granada, GranadaAges 18–70 - NCT06834724Recruiting
CPAP for sleep apnea and chronic pain
This study looks at whether CPAP treatment improves pain and daily life in people who have both sleep apnea and chronic pain. It tests if starting CPAP for the first time can help these symptoms.
BrusselsAges 18 years+ - NCT06830382Recruiting
HER2-PET scan for metastatic breast cancer treatment
This trial uses a special PET scan (HER2-PET) to see if a targeted drug (trastuzumab deruxtecan) works better for your type of metastatic breast cancer. The goal is to match the treatment to how much HER2 protein your tumors show.
SolnaAges 18 years+ - NCT06833593Recruiting
Antibiotic combinations for enterococcus blood infection
This study looks at whether using two or more antibiotics together works better than one alone for a specific type of blood infection caused by Enterococcus faecalis bacteria. The goal is to find the safest and most effective way to treat this infection and improve outcomes for patients.
Bologna, BolognaAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,310 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.